House Bill 1362
116th Congress(2019-2020)
Medical Innovation Never Stops Act of 2019
Introduced
Introduced in House on Feb 26, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1362
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Tom Emmer
grade
Minnesota
No House votes have been held for this bill.
Summary
Medical Innovation Never Stops Act of 2019
This bill requires the Food and Drug Administration (FDA)to accept and review new medical device applications and associated user fees during a lapse in appropriations.Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.
February 26, 2019
02/27/2019
Referred to the Subcommittee on Health.
02/26/2019
Referred to the House Committee on Energy and Commerce.
02/26/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 4:32:51 PM